Current approaches in identification and isolation of human renal cell carcinoma cancer stem cells

被引:0
作者
Mohammed I. Khan
Anna M. Czarnecka
Igor Helbrecht
Ewa Bartnik
Fei Lian
Cezary Szczylik
机构
[1] Military Institute of Medicine,Molecular Oncology Laboratory, Clinic of Oncology
[2] University of Warsaw,Institute of Genetics and Biotechnology, Faculty of Biology
[3] Polish Academy of Sciences,Institute of Biochemistry and Biophysics
[4] Emory University School of Medicine,Department of Urology
来源
Stem Cell Research & Therapy | / 6卷
关键词
Renal Cell Carcinoma; CD105; Side Population; Renal Cell Carcinoma Cell; Side Population Cell;
D O I
暂无
中图分类号
学科分类号
摘要
In recent years, cancer stem cells (CSCs)/tumor initiating cells (TICs) have been identified inside different tumors. However, currently used anti-cancer therapies are mostly directed against somatic tumor cells without targeting CSCs/TICs. CSCs/TICs also gain resistance to chemotherapies/radiotherapies. For the development of efficient treatment strategies, choosing the best method for isolation and characterization of CSCs/TICs is still debated among the scientific community. In this review, we summarize recent data concerning isolation techniques for CSCs using magnetic cell sorting and flow cytometry. The review focuses on the strategies for sample preparation during flow cytometric analysis, elaborating biomarkers such as CXCR4, CD105, and CD133. In addition, functional properties characteristic of CSCs/TICs using side population selection through Hoechst 33342 dye, aldehyde dehydrogenase 1, dye-cycle violet, and rhodamine 123 are also discussed. We also include a special focus on enriching CSCs/TICs using three-dimensional cell culture models such as agarose–agarose microbeads and sphere formation.
引用
收藏
相关论文
共 383 条
[1]  
Duff SE(2003)CD105 is important for angiogenesis: evidence and potential applications FASEB J. 17 984-92
[2]  
Li C(2008)Identification of a tumor-initiating stem cell population in human renal carcinomas FASEB J. 22 3696-705
[3]  
Garland JM(2013)CD133: a stem cell biomarker and beyond Exp Hematol Oncol. 2 17-44
[4]  
Kumar S(2010)Epigenetic regulation of cancer stem cell marker CD133 by transforming growth factor-beta Hepatology. 51 1635-55
[5]  
Bussolati B(2005)Isolation of renal progenitor cells from adult human kidney Am J Pathol. 166 545-35
[6]  
Bruno S(2006)CD133+ renal progenitor cells contribute to tumor angiogenesis Am J Pathol. 169 2223-41
[7]  
Grange C(2014)CTR2 identifies a population of cancer cells with stem-like features in patients with clear cell renal cell carcinoma J Urol. 192 1831-2003
[8]  
Ferrando U(2002)The essential roles of the chemokine SDF-1 and its receptor CXCR4 in human stem cell homing and repopulation of transplanted immune-deficient NOD/SCID and NOD/SCID/B2m(null) mice Leukemia. 16 1992-94
[9]  
Camussi G(2005)Trafficking of normal stem cells and metastasis of cancer stem cells involve similar mechanisms: pivotal role of the SDF-1–CXCR4 axis Stem Cells. 23 879-57
[10]  
Li Z(2013)The Role of chemokine receptor CXCR4 in breast cancer metastasis Am J Cancer Res. 3 46-6